Inventor · disambiguated record
Jill P. Smith
Also filed as: SMITH JILL · SMITH JILL P
18 granted patents·15 pending applications·93 citations·filing 1997–2025
92Inventor score
Files withPENN STATE RES FOUND11UNIV GEORGETOWN8CANCER ADVANCES INC7SMITH JILL P4LEO VERIFICATION SYSTEMS INC1
Top patents by PatentIndex Score
33 records- 0193US8003630B2Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptorPENN STATE RES FOUND·Filed 2006·Granted Aug 23, 2011·10 cites·10 claims
- 0286US6737397B1Control of cancer growth through the interaction of [MET5]-enkephalin and the zeta receptorPENN STATE RES FOUND·Filed 2000·Granted May 18, 2004·21 cites·5 claims
- 0382US11278551B2Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitorUNIV GEORGETOWN·Filed 2018·Granted Mar 22, 2022·2 cites·29 claims
- 0480US11583576B2Compositions and methods for inducing humoral and cellular immunities against tumors and cancerCANCER ADVANCES INC·Filed 2018·Granted Feb 21, 2023·2 cites·11 claims
- 0580US5849800AUse of amantadine for treatment of Hepatitis CPENN STATE RES FOUND·Filed 1997·Granted Dec 15, 1998·49 cites·21 claims
- 0679US8889640B1Composition and method for the treatment of gastrin mediated cancersSMITH JILL P·Filed 2009·Granted Nov 18, 2014·4 cites·6 claims
- 0776US7879870B2Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonistsSMITH JILL P·Filed 2007·Granted Feb 1, 2011·3 cites·20 claims
- 0876US2025242007A1Compositions and methods for inducing humoral and cellular immunities against tumors and cancerCANCER ADVANCES INC·Filed 2024·Application pending·0 cites
- 0975US12076383B2Compositions and methods for inducing humoral and cellular immunities against tumors and cancerCANCER ADVANCES INC·Filed 2022·Granted Sep 3, 2024·0 cites·9 claims
- 1075US2024216391A1Treating fibrosis with a cck receptor inhibitorUNIV GEORGETOWN·Filed 2024·Application pending·0 cites
- 1173US12453735B2Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitorUNIV GEORGETOWN·Filed 2022·Granted Oct 28, 2025·0 cites·6 claims
- 1273US12251364B2Treating non-alcoholic steatohepatitis with cck inhibitorsUNIV GEORGETOWN·Filed 2019·Granted Mar 18, 2025·0 cites·10 claims
- 1373US2025319171A1Compositions and methods for preventing tumors and cancerCANCER ADVANCES INC·Filed 2024·Application pending·0 cites
- 1472US9149544B2Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivoMORGAN THOMAS T·Filed 2010·Granted Oct 6, 2015·2 cites·2 claims
- 1571US2021046147A1Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptorPENN STATE RES FOUND·Filed 2020·Application pending·0 cites
- 1668US9375458B2Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptorPENN STATE RES FOUND·Filed 2012·Granted Jun 28, 2016·0 cites·4 claims
- 1766US2021338705A1Encapsulation and high encapsulation efficiency of phosphorylated active agents in nanoparticlesPENN STATE RES FOUND·Filed 2021·Application pending·0 cites
- 1865US11696922B2Nanoparticle to target cancerUNIV GEORGETOWN·Filed 2021·Granted Jul 11, 2023·0 cites·10 claims
- 1965US2016256517A1Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptorPENN STATE RES FOUND·Filed 2016·Application pending·0 cites
- 2065US2025369965A1Formulation, a kit, and method for food allergen detectionLEO VERIFICATION SYSTEMS INC·Filed 2025·Application pending·0 cites
- 2164US10668126B2Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptorZAGON IAN S·Filed 2005·Granted Jun 2, 2020·0 cites·14 claims
- 2263US12150978B2Compositions and methods for preventing tumors and cancerCANCER ADVANCES INC·Filed 2021·Granted Nov 26, 2024·0 cites·26 claims
- 2362US2011123437A1Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptorPENN STATE RES FOUND·Filed 2011·Application pending·0 cites
- 2462US2025332130A1Treating non-alcoholic steatohepatitis with cck inhibitorsUNIV GEORGETOWN·Filed 2025·Application pending·0 cites
- 2558US9562095B2Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibodySMITH JILL P·Filed 2014·Granted Feb 7, 2017·0 cites·2 claims
- 2656US2019255087A1Encapsulation and high loading efficiency of phosphorylated drug and imaging agents in nanoparticlesPENN STATE RES FOUND·Filed 2019·Application pending·0 cites
- 2755US2024398917A1Compositions and methods for preventing tumors and cancerCANCER ADVANCES INC·Filed 2022·Application pending·0 cites
- 2854US11246881B2Nanoparticle to target cancerUNIV GEORGETOWN·Filed 2017·Granted Feb 15, 2022·0 cites·33 claims
- 2953US2023398196A1Compositions and methods for enhancing t cell penetration of tumors and cancersCANCER ADVANCES INC·Filed 2021·Application pending·0 cites
- 3049US2024252696A1Targeting the cholecystokinin-b receptor for imaging and early detection of pancreatic cancer and pre-cancerous lesionsUNIV GEORGETOWN·Filed 2021·Application pending·0 cites
- 3149US2017209478A1Encapsulation and high loading efficiency of phosphorylated drug and imaging agents in nanoparticlesPENN STATE RES FOUND·Filed 2017·Application pending·0 cites
- 3248US2017274100A1Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells in VivoPENN STATE RES FOUND·Filed 2015·Application pending·0 cites
- 3347US8821872B2Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancerSMITH JILL P·Filed 2010·Granted Sep 2, 2014·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Jill P. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →